1. Home
  2. CTXR vs LGCB Comparison

CTXR vs LGCB Comparison

Compare CTXR & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • LGCB
  • Stock Information
  • Founded
  • CTXR 2007
  • LGCB 2011
  • Country
  • CTXR United States
  • LGCB Japan
  • Employees
  • CTXR N/A
  • LGCB N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • CTXR Health Care
  • LGCB
  • Exchange
  • CTXR Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • CTXR 19.8M
  • LGCB 23.4M
  • IPO Year
  • CTXR N/A
  • LGCB 2023
  • Fundamental
  • Price
  • CTXR $1.49
  • LGCB $2.05
  • Analyst Decision
  • CTXR Buy
  • LGCB
  • Analyst Count
  • CTXR 2
  • LGCB 0
  • Target Price
  • CTXR $6.00
  • LGCB N/A
  • AVG Volume (30 Days)
  • CTXR 570.6K
  • LGCB 58.7K
  • Earning Date
  • CTXR 12-26-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • CTXR N/A
  • LGCB N/A
  • EPS Growth
  • CTXR N/A
  • LGCB N/A
  • EPS
  • CTXR N/A
  • LGCB N/A
  • Revenue
  • CTXR N/A
  • LGCB $8,993,265.00
  • Revenue This Year
  • CTXR N/A
  • LGCB N/A
  • Revenue Next Year
  • CTXR $731.60
  • LGCB N/A
  • P/E Ratio
  • CTXR N/A
  • LGCB N/A
  • Revenue Growth
  • CTXR N/A
  • LGCB 5.80
  • 52 Week Low
  • CTXR $0.65
  • LGCB $1.22
  • 52 Week High
  • CTXR $5.95
  • LGCB $6.83
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 59.09
  • LGCB 54.46
  • Support Level
  • CTXR $0.97
  • LGCB $1.85
  • Resistance Level
  • CTXR $1.18
  • LGCB $2.09
  • Average True Range (ATR)
  • CTXR 0.12
  • LGCB 0.17
  • MACD
  • CTXR 0.03
  • LGCB 0.02
  • Stochastic Oscillator
  • CTXR 84.72
  • LGCB 64.62

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: